- Home
- PYPD vs GROW Comparison
PYPD vs GROW Comparison
Compare PYPD & GROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- GROW
- Stock Information
- Founded
- PYPD 2008
- GROW 1968
- Country
- PYPD Israel
- GROW United States
- Employees
- PYPD N/A
- GROW N/A
- Industry
- PYPD Medical/Dental Instruments
- GROW Investment Managers
- Sector
- PYPD Health Care
- GROW Finance
- Exchange
- PYPD Nasdaq
- GROW Nasdaq
- Market Cap
- PYPD 34.8M
- GROW 32.2M
- IPO Year
- PYPD 2020
- GROW N/A
- Fundamental
- Price
- PYPD $3.49
- GROW $2.55
- Analyst Decision
- PYPD Strong Buy
- GROW
- Analyst Count
- PYPD 5
- GROW 0
- Target Price
- PYPD $12.00
- GROW N/A
- AVG Volume (30 Days)
- PYPD 52.0K
- GROW 23.0K
- Earning Date
- PYPD 11-12-2025
- GROW 09-08-2025
- Dividend Yield
- PYPD N/A
- GROW 3.56%
- EPS Growth
- PYPD N/A
- GROW N/A
- EPS
- PYPD N/A
- GROW N/A
- Revenue
- PYPD N/A
- GROW $8,452,000.00
- Revenue This Year
- PYPD N/A
- GROW N/A
- Revenue Next Year
- PYPD N/A
- GROW N/A
- P/E Ratio
- PYPD N/A
- GROW N/A
- Revenue Growth
- PYPD N/A
- GROW N/A
- 52 Week Low
- PYPD $2.30
- GROW $2.02
- 52 Week High
- PYPD $3.93
- GROW $2.68
- Technical
- Relative Strength Index (RSI)
- PYPD 54.23
- GROW 61.52
- Support Level
- PYPD $3.35
- GROW $2.39
- Resistance Level
- PYPD $3.54
- GROW $2.57
- Average True Range (ATR)
- PYPD 0.12
- GROW 0.06
- MACD
- PYPD 0.00
- GROW 0.01
- Stochastic Oscillator
- PYPD 75.49
- GROW 80.05
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About GROW U.S. Global Investors Inc.
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.